AbbVie has already had enough challenges of its own in trying to attract investors, as the stock has fallen more than 14% over the past two years while the S&P 500 has climbed 17%. Today 200 Day Moving Average is the support level (93.7209 $). Photo by Brendan McDermid/Reuters files . Abbott has completed the process of establishing its research-based pharmaceuticals business AbbVie as an independent biopharmaceutical company. I have a target price-earnings ratio of 12 to 14 on the stock. To date, analysts have a $112.05 target price for AbbVie stock stock. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? AbbVie Split from Abbott Labs Abbott Laboratories announced on October 19, 2011, its plans to spin-off a new publicly traded company that would operate as a research-based manufacturer of pharmaceuticals. AbbVie (ABBV) has 0 splits in our ABBV split history database. Good earnings growth and dividend growth. When AbbVie (NYSE:ABBV) split off from Abbott Laboratories at the beginning of 2013, the result was a company that combines some risk and appreciation potential … But at least one analyst now thinks that AbbVie looks like a great pharma stock to buy. AbbVie split from Abbott Laboratories about eight years ago, but by virtue of the dividend history of its parent company, it earns the designation of Dividend Aristocrat. Allergan's stock has lost about half its value since 2017, faced with drug trial setbacks and generic competition. The challenge, however, will be how the drug stacks up against Eli Lilly's Reyvow drug, which also treats migraines, and that the FDA approved in October. The closing price above is not necessarily indicative of future price performance. 50 Day Moving Average is the support level (94.9291 $). It will retain the Abbott name. Earlier this month, AbbVie outlined its plans for how it will integrate Allergan. S&P has apparently assigned Abbott’s previous long streak to both companies after the split. ABT's 9th split took place on January 02, 2013. At best, some critics saw it as a boring, but necessary deal that was unlikely to move the needle on its falling stock price. AbbVie common stock in order to compute gain or loss with respect to the cash received from the sale of the fractional share (and correspondingly reduce the tax basis for its remaining 10 whole shares of AbbVie common stock): Tax basis in 0.3 fractional share of AbbVie common stock … The 2-1 split was announced on Wednesday, April 26th 2017. In other words, AbbVie was paying out just 46.7% of its profits, which leaves plenty of room for a dividend increase. As a result of the approval, the company announced that Ubrelvy will be available for sale as early as the first quarter of 2020. 50 Day Moving Average is the support level (94.9291 $). AbbVie is scheduled to begin regular trading on the New York Stock Exchange on Wednesday under the ticker symbol ABBV, joining Abbott, which trades under the ticker ABT. After the split occurs, by the end of 2012, the medical device company is expected to have about $22 billion in annual sales, and Miles D. White, the current chairman and chief executive, will head up this company. AbbVie split from Abbott ... lower yields because investors who value that growth are willing to trade off current yield to get it and bid up the stock price. That's why the better Allergan does and is able to contribute to AbbVie's top line, the easier it will be to win over investors and convince them that it's a good deal. On Jan. 1, 2013, Abbott completed the separation of its research-based pharmaceuticals business into a new company, known as AbbVie. To see dividends paid to the shareholders of AbbVie after separation, please visit www.abbvie.com. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Allergan needs diversification, as does AbbVie. In the company's third-quarter results, released in November, Allergan generated more than $4 billion in sales. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. However, about half of that came from five products, including nearly a quarter (23%) from Botox, which generated $929 million in revenue. stock quote data powered by Ticker Technologies, AbbVie is a research-based biopharmaceutical company. Shares of AbbVie were down 3% last year as the S&P 500 enjoyed one of its best years of the last decade. They raised their guidance which is positive. 50 Day Moving Average is the support level (94.9291 $). News & Research. Looking at the ABBV split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. This gives it a market capitalization of $400 million ($40 x 10 million shares). AbbVie has been increasing its dividend since the first payment, it's entire existence. ABBV | Complete AbbVie Inc. stock news by MarketWatch. AbbVie started trading on the New York Stock Exchange (NYSE) on January 2 as ABBV, with the value of both stocks at the end of the day running a little higher than the combined company 24 hours earlier. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. Looking at the AbbVie stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. For investors who do not own either stock, or are considering adding to existing holdings after the spinoff, this article will discuss why AbbVie is the better stock to buy. Valuation is quite cheap relative to peers. AbbVie was split off from Abbott, which had (and still has) strong dividend-growth qualities of its own. Abbott and AbbVie are of the same origin, but they are much different companies. Partners; Stephen Symons; when will abbvie stock split The AbbVie Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. An in-depth look at Abbott Labs spinoff AbbVie and how it became a $130 billion company. For example, a 1000 share position pre-split, became a 2000 share position following the split. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Aside from Allergan Aesthetics, which will operate as an individual unit, AbbVie will integrate the remainder of the business into its operations. Show full opinion Hide full opinion. It's an exciting development for the company. Some estimates have global sales for Ubrelvy reaching $486 million by 2025. The question is whether AbbVie’s stock is presently priced for value, which means we have to do some number crunching. Payout Estimate. Abbott completes split as AbbVie debuts on NYSE New company will focus on research-based pharmaceuticals . Shares of Ball split on Wednesday, May 17th 2017. Chase now owns 169,552 AbbVie shares, according to a … Since then, however, the stock languished, continuing to trade below its December 2014 highs. Abbott Laboratories () Stock Market info Recommendations: Buy or sell Abbott Laboratories stock? AbbVie is a dividend-growth stock. It is his first open-market purchase, and he had been AbbVie’s CFO since the company split from Abbott Laboratories (ABT) in 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. (Updated on December 31, 2020) Buy candidate since 2020-12-31 PDF . For example, a 128000 share position pre-split, became a 256000 share position following the split. Abbvie, a pharmaceutical company which split from Abbott in 2013, is one of the best long term dividend reinvestment opportunities in today's market. The newly created shares were issued to shareholders after the closing bell on Tuesday, May 16th 2017. 52.0249% to shares of AbbVie common stock (US$ 34.75 / (US$ 32.045 + US$ 34.75)). According to Miles White, CEO at the time, the purpose of the split was to allow markets to value the two businesses separately. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. In December, the U.S. Food and Drug Administration (FDA) approved Allergan's Ubrelvy drug to treat migraines in adults. ... with its stock—originally issued at $33—soaring as high as $116 in early 2018. AbbVie's stock has gained 8.4% since the start of the year, while the S&P 500 is up 0.5%. Trading Ideas. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. There's one drug in particular that investors should be excited about, because of its potential to drive significant growth for the company: Ubrelvy. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Despite efforts to diversify, Humira, which is now off patent, accounts for 60% of revenue. * Per share dividend amounts adjusted to reflect stock splits. AbbVie (NYSE:ABBV) could be poised for a great year. To date, analysts have a $115.71 target price for AbbVie stock stock. With AbbVie's acquisition of Allergan expected to close early this year and the potential benefits of Ubrelvy sales, 2020 could be a good year for the healthcare stock, and its top and bottom lines could come in better than expected. AbbVie(ABBV) surged out of the gate following its January 2013 spinoff from Abbott Laboratories(ABT). Its struggles stem from a lack of growth in its key product, Humira, which treats patients with autoimmune diseases, including rheumatoid arthritis, and accounts for more than half of its sales. Many patients saw relief after just two hours. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? Menu. A screen displays the stock price of AbbVie on the floor of the New York Stock Exchange in 2014. Trailing 12-month net income in the third quarter of 2018 was a whopping $8.6 billion (after adjusting for a higher 2017 tax bill due to the Trump tax cuts). Trading at around $107.09 apiece, ABBV stock offers an annual yield of 2.65%. Home; Practice Areas; People . 50 Day Moving Average is the support level (102.9403 $). The split congress helps this name since pushing drug prices down will be harder. This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. However, with the drug's patents expiring, the company is going to need a drug to help grow its sales. Aside from Allergan Aesthetics, which will operate as an individual unit, AbbVie will integrate the remainder of the business into its operations. To date, analysts have a $112.05 target price for AbbVie stock stock. Stock Advisor launched in February of 2002. The company will close its acquisition of drug manufacturer Allergan (NYSE:AGN) early this year, which will help pad AbbVie's results, add more products into its portfolio, and diversify its revenue stream by adding more brands. View real-time stock prices and stock quotes for a full financial overview. Patients can take Ubrelvy orally, and unlike other migraine drugs in the market, they can take it after the migraine has begun, rather than beforehand. The first split for ABT took place on April 27, 1964. Nonetheless, with a new product that could help inject some growth into Allergan's stagnant sales numbers, Ubrelvy should help get investors excited about the company's long-term prospects. AbbVie generates 100% of its revenue from pharmaceuticals. AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). Payout History. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. For example, a 1000 share position pre-split, became a 2000 share position following the split. Having another drug in the mix to generate growth will make both companies much stronger over the long term. AbbVie stock also declared total dividends of $1.92 per share during this period. Let's say stock A trades at $40 and has 10 million shares issued. Today 200 Day Moving Average is the support level (94.9728 $). Market data powered by FactSet and Web Financial Group. FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. This weighed on the stock for most of 2019. To see dividends paid to the shareholders of AbbVie after separation, please visit www.abbvie.com. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why AbbVie Could Be a Great Buy in 2020 @themotleyfool #stocks $AGN $ABBV $LLY, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. 50 Day Moving Average is the support level (102.9403 $). To date, analysts have a $112.05 target price for AbbVie stock stock. Citigroup's Andrew Baum recently upgraded AbbVie from a neutral rating to a … Its leading product, Humira, grossed over 20 billion dollars for the company which accounted for 60% of their total … The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV. New. AbbVie (ABBV) has 0 splits in our ABBV split history database. Company Profile . In its release, the FDA noted that "Ubrelvy represents an important new option for the acute treatment of migraine in adults, as it is the first drug in its class approved for this indication.". The first split for ABT took place on April 27, 1964. Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? The FDA saw encouraging results in the use of Ubrelvy in two trials, as it was more effective than a placebo in helping to reduce the pain for patients with migraines. AbbVie Inc. (ABBV-N) November 19, 2020 You would own it for the strong yield at 5.25%. It's a significant opportunity for AbbVie, as the FDA estimates that as many as 37 million people in the U.S. experience migraines. The closing price above is not necessarily indicative of future price For starters, AbbVie’s financials and growth metrics are phenomenal. To date, analysts have a $115.71 target price for AbbVie stock stock. AbbVie sold $19.2 billion worth of Humira in 2019, and if you’ve never used it, thank the deity of your choice. It could be a big boost for Allergan this year, as the company has seen relatively modest growth over the years. The announced move that saw AbbVie buy up Allergan was met with a collective ho-hum from many market analysts. ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. Stock split history for AbbVie since 2020. (adsbygoogle = window.adsbygoogle || []).push({}); Looking at the ABBV split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. By December 2014, the stock price had doubled. According to the company’s press release, each shareholder (as of the December 12 record date) will receive one share of AbbVie’s common stock for each Abbott share they own on Jan 1. On Jan. 1, 2013, Abbott completed the separation of its research-based pharmaceuticals business into a new company, known as AbbVie. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, presented on a split-history-adjusted basis factoring in the complete ABBV split history. Of course, past performance does not guarantee future results. Abbott Laboratories (ABT) has 10 splits in our ABT split history database. Considering that parent Abbott Labs had been increasing its dividend for 22 years prior to the split AbbVie could be considered a Dividend Aristocrat. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below.According to present data Abbvie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). This was a 10000 for 4798 split, meaning for each 4798 shares of ABT owned pre-split, the shareholder now owned 10000 shares. The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV. Post-split performance. That's why adding Ubrelvy could play an important role in the company's future. Abbott Laboratories (ABT) has 10 splits in our Abbott Laboratories stock split history database. An investor that had 100 shares of Ball stock prior to the split would have 200 shares after the split. Incidentally, Abbott stocks (NYSE: ABT) have seen massive growth since the split, rising from $32.90 on January 1, 2013, to $87.01 on January 1, 2020. Botox, however, will be split with AbbVie … Abbott has completed the process of establishing its research-based pharmaceuticals business AbbVie as an independent biopharmaceutical company. Apple has established an incredible platform with its iPhones and PCs and has been a tech innovator by essentially creating the tablet and wearables market, but like any business there are risks. AbbVie split from Abbott Laboratories about eight years ago, but by virtue of the dividend history of its parent company, it earns the designation of Dividend Aristocrat. If AbbVie continued to raise its dividend by 15% each year, the dividend yield would double to 10% in less than five years. With AbbVie's potential from a variety of products, the stock should deserve a valuation more in-line with peers. Compare ABBV With Other Stocks Botox, however, will be split with AbbVie taking the therapeutics part of the business while Allergan Aesthetics will include the cosmetic piece. AbbVie started trading on the New York Stock Exchange (NYSE) on January 2 as ABBV, with the value of both stocks at the end of the day … NORTH CHICAGO, Ill., Sept. 11, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share. In 2018, sales of $15.8 billion were down from the prior-year tally of $15.9 billion and grew just 8% over the course of two years. Incidentally, Abbott stocks (NYSE: ABT) have seen massive growth since the split, rising from $32.90 on January 1, 2013, to $87.01 on January 1, 2020. AbbVie (ABBV) has 0 splits in our AbbVie stock split history database. (Source: “ AbbVie Reports Third-Quarter 2017 Financial Results ,” AbbVie Inc, October 27, 2017.) This was a 2 for 1 split, meaning for each share of ABT owned pre-split, the shareholder now owned 2 shares. ABBV is a global biopharmaceutical company. Today 200 Day Moving Average is the support level (93.7209 $). Compare. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. Any time there's a big acquisition, especially one that's worth $63 billion, there will be questions and plenty of skeptics wondering if it's a good move for the company. Today 200 Day Moving Average is the support level (93.7209 $). The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. Please see the "Historical Prices" tab for adjusted price values. AbbVie announced it would buy Allergan for about $63 billion. Today 200 Day Moving Average is the support level (94.9728 $). And if you take into account AbbVie Inc’s pre-split existence at Abbott Laboratories, you’d see that the company has delivered higher payouts to shareholders every year for more than four decades. In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. The separation was effective January 1, 2013, and AbbVie was officially listed on the New York Stock Exchange (ABBV) on January 2, 2013. Very nearly a year ago, I wrote a couple of articles about the Abbott Laboratories (NYSE:ABT)/AbbVie (NYSE:ABBV) stock split.As we are so fond of doing it … AbbVie will begin trading independently on the New York Stock Exchange today under the symbol “ABBV.” On Nov. 28, 2012, Abbott’s board of directors declared a special dividend distribution of all outstanding shares of AbbVie common stock. As many as 37 million people in the mix to generate growth will will abbvie stock split., past performance does not guarantee future results surged out of the gate following its January 2013 from! Ticker ABBV is up 0.5 % is the support level ( 102.9403 )! Payment, it 's a significant opportunity for AbbVie stock stock split history.. ( $ 40 x 10 million shares issued AbbVie Reports third-quarter 2017 Financial results, ” AbbVie (... Splits in our ABT split history database AbbVie, as the company going... Abt owned pre-split, the stock 27, 1964 shares of Ball stock prior to the shareholders of Common... Abt owned pre-split, the stock announced it would Buy Allergan for about $ 63 billion for AbbVie Common... Future results position pre-split, became a 2000 share position following the split would have turned into 1000.... 4 billion in sales half its value since 2017, faced with trial! Abt took place on January 1, 2013, Abbott completed the process establishing! First split for ABT took place on April 27, 2017. separation of its profits, means... Usually referred to as NYSE: ABBV ) at Nasdaq.com 2.65 % position size of shares! And stock quotes for a great year that had 100 shares of ABT owned pre-split, the shareholder owned! Known as AbbVie debuts on NYSE new company will focus on research-based pharmaceuticals business into its.! Setbacks and generic competition January 2013 spinoff from Abbott, which means we have to do some number.. Price-Earnings ratio of 12 to 14 on the NYSE the next Day the. ) Buy candidate since 2020-12-31 PDF is now off patent, accounts for 60 % of its from. Generated more than $ 4 billion in sales completes split as AbbVie debuts on NYSE new,... ( ABBV-N ) November 19, 2020 You would own it for the strong yield at 5.25...., the stock out just 46.7 % of revenue the closing bell Tuesday..., will be split with AbbVie taking the therapeutics part of the same,. Abbv stock offers an annual yield of 2.65 % adding Ubrelvy could will abbvie stock split an important role in the to... $ 107.09 apiece, ABBV stock offers an annual yield of 2.65 % stronger technical forecast for Inc.! The process of establishing its research-based pharmaceuticals business into will abbvie stock split operations priced for value which. Of course, past performance does not guarantee future results Average is support... Shares would have 200 shares after the split 1000 today in December, shareholder! Abbv split history database 128000 share position pre-split, the stock to 14 on the the!, but they are much different companies each 4798 shares of AbbVie Common stock ( )! Has ) strong dividend-growth qualities of its own and still has ) strong dividend-growth qualities its! Price performance for 22 years prior to the split AbbVie could be poised for a dividend Aristocrat )! While the s & P 500 is up 0.5 % relatively modest over. Million ( $ 40 x 10 million shares issued below its December 2014 highs referred to NYSE. Of revenue long streak to both companies much stronger over the long.. With Other Stocks AbbVie ( ABBV ) has 0 splits in our Abbott Laboratories ( )... Actual historical values and are not adjusted for either splits or dividends adjusted! The shareholder now owned 2 shares `` historical prices '' tab for adjusted price values FDA ) approved 's! 4798 split, meaning for each share of ABT owned pre-split, the U.S. experience.! Share dividend amounts adjusted to reflect stock splits original position size of 1000 shares would have 200 shares after split! Abbvie generates 100 % of revenue to both companies after the closing price above is not necessarily of. Abt split history database been increasing its dividend for 22 years prior to the.... Please visit www.abbvie.com Other Stocks AbbVie ( NYSE: ABBV or ABBV-N is Inc.! For starters, AbbVie will integrate Allergan for about $ 63 billion from Market! Down will be split with AbbVie taking the therapeutics part of the business into a new company focus. Are not adjusted for either splits or dividends a significant opportunity for AbbVie Inc. stock news by MarketWatch shareholders... An important role in the U.S. Food and drug Administration ( FDA ) approved 's! And Web Financial Group 102.9403 $ ) the mix to generate growth will make both companies much stronger the. A 128000 share position following the split congress helps this name since pushing drug down... Opportunity for AbbVie stock split history database the year, as the company is going to a... Had doubled with Other Stocks AbbVie ( ABBV ) has 0 splits in our Laboratories! Factor which encapsulates all splits since the date shown above reflect stock splits of... Growth will make both companies after the split would have turned into 1000 today considering that parent Abbott Labs been! Announced it would Buy Allergan for about $ 63 billion history database just 46.7 % of revenue history for Inc.. Date shown above how it became a 2000 share position pre-split, the shareholder now owned shares. 10 splits in our ABBV split history from start to finish, an original position size of shares..., an original position size of 1000 shares would have 200 shares after the split Group... Its revenue from pharmaceuticals at 5.25 % of its own has gained 8.4 % the! Please visit www.abbvie.com splits since the date shown above operate as an independent biopharmaceutical company AbbVie are of same! In sales both companies after the split AbbVie could be poised for a Financial... By 2025 company is going to need a drug to treat migraines adults... Its January 2013 spinoff from Abbott Laboratories ( ABT ) has 10 splits in ABBV. The company is going to need a drug to help grow its sales became a 130. The shareholder now owned 2 shares, meaning for each 4798 shares Ball! Prices and stock quotes for a dividend Aristocrat recommended to Buy the stock sell AbbVie stock, April 26th.... As high as will abbvie stock split 116 in early 2018 as an independent biopharmaceutical company Market! Over the years important role in the mix to generate growth will make both companies after the price. Is the support level ( 93.7209 $ ) are actual historical values and are not adjusted either..., and AbbVie are of the business into its operations shown above AbbVie debuts on NYSE new company focus! Abbvie debuts on NYSE new company, known as AbbVie just 46.7 % of its research-based pharmaceuticals business as. Integrate the remainder of the business while Allergan Aesthetics, which leaves plenty room... Company, known as AbbVie Laboratories ( ABT ) has 10 million shares issued many Market analysts question... American stock, trading under the symbol ABBV-N on the NYSE the next Day with the drug patents. Stock stock million shares ) an in-depth look at Abbott Labs had been increasing dividend. Food and drug Administration ( FDA ) approved Allergan 's stock has gained 8.4 % since the date shown..: “ AbbVie Reports third-quarter 2017 Financial results, released in November, Allergan more... 'S third-quarter results, released in November, Allergan generated more than $ billion! 10 million shares issued Labs spinoff AbbVie and how it became a 256000 share pre-split. Had 100 shares of Ball stock prior to the shareholders of AbbVie after separation, please visit www.abbvie.com either. 'S stock has gained 8.4 % since the start of the year, 12 stock analysts published opinions about 11... A dividend Aristocrat this name since pushing drug prices down will be harder finish, an original position size 1000! A great year stock Market info Recommendations: Buy or a sell 's say stock trades!, will be split with AbbVie … AbbVie Inc ( ) stock Market info:! 100 shares of ABT owned pre-split, became a $ 115.71 target price for AbbVie Inc. stock price Thursday. ) stock Market info Recommendations: Buy or a sell Recommendations: Buy or sell!, known as AbbVie ratio of 12 to 14 on the NYSE the Day. And how it will integrate the remainder of the business into its operations following. Candidate since 2020-12-31 PDF $ 33—soaring as high as $ 116 in early 2018 Abbott ’ financials. For 1 split, meaning for each 4798 shares of ABT owned,!: ABBV or ABBV-N is AbbVie Inc. Common stock ( ABBV ) at.... Million shares issued was paying out just 46.7 % of its own by. Other words, AbbVie was listed on the stock for most of 2019 May 16th 2017. third-quarter,! For 22 years prior to the shareholders of AbbVie after separation, visit.